Theratechnologies Inc T.TH

Presentation post or link?

[Wino115]

Sure would be helpful to hear what was discussed at the Cancer Conf by CMO. Hope they post something on that.

[SPCEO1]

My guess is there was no material info presented, so they had no need to put anything out. But it still would be nice to be able to hear whatever was shared or at least a summary of it.

[SABBOBCAT]

I would have to agree. The PR last week was to communicate the can kicking down the road. There will be no new cancer information until later in the spring. We will have the SAC in late marh, then final prep and submission to the FDA in late April, then 30 days after that the FDA responds. This puts late May as the best case scenario for news. Realistically nothing TH touches is best case scenario

[scarlet1967]

"11:00 am Case Study: A First-In-Class Peptide Drug Conjugate (PDC) Platform Targeting Sortilin (SORT1) Receptor Positive Cancers Christian Marsolais SrVP & CMO, Theratechnologies Inc.   Synopsis Understanding why the normal function of a scavenger receptor, SORT1, can be exploited to rapidly transport novel peptide drug conjugates (PDCs) into cancer cells

[SPCEO1]

What would be truly helpful is to hear the Q&A, or to get report on it by someone in attendance. I doubt  that will happen. They may comment on the presentation next Tuesday but we are unllikey to get the unsanitzed info we would like to hear from whatever might be said on Tuesday's conference call. 

[qwerty22]

I would guess that people attending this conference wouldn't be that concerned with the commercial aspects of this program. I'd guess it was all science orientated, I can't see any Qs that would shed light on the present dilemma.

[qwerty22]

IDK, the most optimistic take I have on that PR is that they were clearing cancer out of the way so they could focus 100% on revenue during the quarterly. Financially, psychologically and emotionally I've parked cancer. If anything positive happens, on any timescale, then I'll be pleasantly surprised!